Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Pharma
J&J acquires CNS specialist Intra-Cellular for $14.6B
J&J has bought out Intra-Cellular Therapies for $14.6 billion. The New York biotech develops and markets products for the central nervous system.
Kevin Dunleavy
Jan 13, 2025 10:29am
Bigger M&A deals to come in 2025 after 'reset' year: reports
Jan 13, 2025 9:06am
2024's top biopharma M&A deals
Jan 13, 2025 3:00am
A $410M obesity debut, Legend, BeiGene and more—Fierce Pharma Asia
Jan 10, 2025 9:00am
Should BeiGene or Legend sell itself in 2025?
Jan 9, 2025 9:15am
In €500M deal, Merck buys Ireland vaccines plant from WuXi Bio
Jan 6, 2025 11:36am
